The efficacy of natalizumab in patients with relapsing multiple sclerosis: subgroup analyses of AFFIRM and SENTINEL

✍ Scribed by M. Hutchinson; L. Kappos; P. A. Calabresi; C. Confavreux; G. Giovannoni; S. L. Galetta; E. Havrdova; F. D. Lublin; D. H. Miller; P. W. O’Connor; J. T. Phillips; C. H. Polman; E.-W. Radue; R. A. Rudick; W. H. Stuart; A. Wajgt; B. Weinstock-Guttman; D. R. Wynn; F. Lynn; M. A. Panzara; for the AFFIRM and SENTINEL Investigators

• Publisher: Springer
• Year: 2009
• Tongue: English
• Weight: 356 KB
• Volume: 256
• Category: Article
• ISSN: 0340-5354
• DOI: 10.1007/s00415-009-0093-1